No reason to even speculate on delisting NOW - because mid march they can apply for a 6 month extension... and I see absolutely no reason what-so-ever why they would not be granted that.
Six months in the life of an emerging biotech can be transformational.
Just as it has gone from $3+ to 60 cents... it can as readily go from 60 cents to $3+...
Furthermore... everyone here knows that, which is why they are still here... or they would be gone!!!